\documentclass[11pt,twoside]{article}\makeatletter

\IfFileExists{xcolor.sty}%
  {\RequirePackage{xcolor}}%
  {\RequirePackage{color}}
\usepackage{colortbl}
\usepackage{wrapfig}
\usepackage{ifxetex}
\ifxetex
  \usepackage{fontspec}
  \usepackage{xunicode}
  \catcode`⃥=\active \def⃥{\textbackslash}
  \catcode`❴=\active \def❴{\{}
  \catcode`❵=\active \def❵{\}}
  \def\textJapanese{\fontspec{Noto Sans CJK JP}}
  \def\textChinese{\fontspec{Noto Sans CJK SC}}
  \def\textKorean{\fontspec{Noto Sans CJK KR}}
  \setmonofont{DejaVu Sans Mono}
  
\else
  \IfFileExists{utf8x.def}%
   {\usepackage[utf8x]{inputenc}
      \PrerenderUnicode{–}
    }%
   {\usepackage[utf8]{inputenc}}
  \usepackage[english]{babel}
  \usepackage[T1]{fontenc}
  \usepackage{float}
  \usepackage[]{ucs}
  \uc@dclc{8421}{default}{\textbackslash }
  \uc@dclc{10100}{default}{\{}
  \uc@dclc{10101}{default}{\}}
  \uc@dclc{8491}{default}{\AA{}}
  \uc@dclc{8239}{default}{\,}
  \uc@dclc{20154}{default}{ }
  \uc@dclc{10148}{default}{>}
  \def\textschwa{\rotatebox{-90}{e}}
  \def\textJapanese{}
  \def\textChinese{}
  \IfFileExists{tipa.sty}{\usepackage{tipa}}{}
\fi
\def\exampleFont{\ttfamily\small}
\DeclareTextSymbol{\textpi}{OML}{25}
\usepackage{relsize}
\RequirePackage{array}
\def\@testpach{\@chclass
 \ifnum \@lastchclass=6 \@ne \@chnum \@ne \else
  \ifnum \@lastchclass=7 5 \else
   \ifnum \@lastchclass=8 \tw@ \else
    \ifnum \@lastchclass=9 \thr@@
   \else \z@
   \ifnum \@lastchclass = 10 \else
   \edef\@nextchar{\expandafter\string\@nextchar}%
   \@chnum
   \if \@nextchar c\z@ \else
    \if \@nextchar l\@ne \else
     \if \@nextchar r\tw@ \else
   \z@ \@chclass
   \if\@nextchar |\@ne \else
    \if \@nextchar !6 \else
     \if \@nextchar @7 \else
      \if \@nextchar (8 \else
       \if \@nextchar )9 \else
  10
  \@chnum
  \if \@nextchar m\thr@@\else
   \if \@nextchar p4 \else
    \if \@nextchar b5 \else
   \z@ \@chclass \z@ \@preamerr \z@ \fi \fi \fi \fi
   \fi \fi  \fi  \fi  \fi  \fi  \fi \fi \fi \fi \fi \fi}
\gdef\arraybackslash{\let\\=\@arraycr}
\def\@textsubscript#1{{\m@th\ensuremath{_{\mbox{\fontsize\sf@size\z@#1}}}}}
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\def\abbr{}
\def\corr{}
\def\expan{}
\def\gap{}
\def\orig{}
\def\reg{}
\def\ref{}
\def\sic{}
\def\persName{}\def\name{}
\def\placeName{}
\def\orgName{}
\def\textcal#1{{\fontspec{Lucida Calligraphy}#1}}
\def\textgothic#1{{\fontspec{Lucida Blackletter}#1}}
\def\textlarge#1{{\large #1}}
\def\textoverbar#1{\ensuremath{\overline{#1}}}
\def\textquoted#1{‘#1’}
\def\textsmall#1{{\small #1}}
\def\textsubscript#1{\@textsubscript{\selectfont#1}}
\def\textxi{\ensuremath{\xi}}
\def\titlem{\itshape}
\newenvironment{biblfree}{}{\ifvmode\par\fi }
\newenvironment{bibl}{}{}
\newenvironment{byline}{\vskip6pt\itshape\fontsize{16pt}{18pt}\selectfont}{\par }
\newenvironment{citbibl}{}{\ifvmode\par\fi }
\newenvironment{docAuthor}{\ifvmode\vskip4pt\fontsize{16pt}{18pt}\selectfont\fi\itshape}{\ifvmode\par\fi }
\newenvironment{docDate}{}{\ifvmode\par\fi }
\newenvironment{docImprint}{\vskip 6pt}{\ifvmode\par\fi }
\newenvironment{docTitle}{\vskip6pt\bfseries\fontsize{22pt}{25pt}\selectfont}{\par }
\newenvironment{msHead}{\vskip 6pt}{\par}
\newenvironment{msItem}{\vskip 6pt}{\par}
\newenvironment{rubric}{}{}
\newenvironment{titlePart}{}{\par }

\newcolumntype{L}[1]{){\raggedright\arraybackslash}p{#1}}
\newcolumntype{C}[1]{){\centering\arraybackslash}p{#1}}
\newcolumntype{R}[1]{){\raggedleft\arraybackslash}p{#1}}
\newcolumntype{P}[1]{){\arraybackslash}p{#1}}
\newcolumntype{B}[1]{){\arraybackslash}b{#1}}
\newcolumntype{M}[1]{){\arraybackslash}m{#1}}
\definecolor{label}{gray}{0.75}
\def\unusedattribute#1{\sout{\textcolor{label}{#1}}}
\DeclareRobustCommand*{\xref}{\hyper@normalise\xref@}
\def\xref@#1#2{\hyper@linkurl{#2}{#1}}
\begingroup
\catcode`\_=\active
\gdef_#1{\ensuremath{\sb{\mathrm{#1}}}}
\endgroup
\mathcode`\_=\string"8000
\catcode`\_=12\relax

\usepackage[a4paper,twoside,lmargin=1in,rmargin=1in,tmargin=1in,bmargin=1in,marginparwidth=0.75in]{geometry}
\usepackage{framed}

\definecolor{shadecolor}{gray}{0.95}
\usepackage{longtable}
\usepackage[normalem]{ulem}
\usepackage{fancyvrb}
\usepackage{fancyhdr}
\usepackage{graphicx}
\usepackage{marginnote}

\renewcommand{\@cite}[1]{#1}


\renewcommand*{\marginfont}{\itshape\footnotesize}

\def\Gin@extensions{.pdf,.png,.jpg,.mps,.tif}

  \pagestyle{fancy}

\usepackage[pdftitle={Anti-Cancer Activities of Cu(?) Ion Solution in Progression and Development against Cancer and Tumor Cells},
 pdfauthor={}]{hyperref}
\hyperbaseurl{}

	 \paperwidth210mm
	 \paperheight297mm
              
\def\@pnumwidth{1.55em}
\def\@tocrmarg {2.55em}
\def\@dotsep{4.5}
\setcounter{tocdepth}{3}
\clubpenalty=8000
\emergencystretch 3em
\hbadness=4000
\hyphenpenalty=400
\pretolerance=750
\tolerance=2000
\vbadness=4000
\widowpenalty=10000

\renewcommand\section{\@startsection {section}{1}{\z@}%
     {-1.75ex \@plus -0.5ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large\bfseries}}
\renewcommand\subsection{\@startsection{subsection}{2}{\z@}%
     {-1.75ex\@plus -0.5ex \@minus- .2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\Large}}
\renewcommand\subsubsection{\@startsection{subsubsection}{3}{\z@}%
     {-1.5ex\@plus -0.35ex \@minus -.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\large}}
\renewcommand\paragraph{\@startsection{paragraph}{4}{\z@}%
     {-1ex \@plus-0.35ex \@minus -0.2ex}%
     {0.5ex \@plus .2ex}%
     {\reset@font\normalsize}}
\renewcommand\subparagraph{\@startsection{subparagraph}{5}{\parindent}%
     {1.5ex \@plus1ex \@minus .2ex}%
     {-1em}%
     {\reset@font\normalsize\bfseries}}


\def\l@section#1#2{\addpenalty{\@secpenalty} \addvspace{1.0em plus 1pt}
 \@tempdima 1.5em \begingroup
 \parindent \z@ \rightskip \@pnumwidth 
 \parfillskip -\@pnumwidth 
 \bfseries \leavevmode #1\hfil \hbox to\@pnumwidth{\hss #2}\par
 \endgroup}
\def\l@subsection{\@dottedtocline{2}{1.5em}{2.3em}}
\def\l@subsubsection{\@dottedtocline{3}{3.8em}{3.2em}}
\def\l@paragraph{\@dottedtocline{4}{7.0em}{4.1em}}
\def\l@subparagraph{\@dottedtocline{5}{10em}{5em}}
\@ifundefined{c@section}{\newcounter{section}}{}
\@ifundefined{c@chapter}{\newcounter{chapter}}{}
\newif\if@mainmatter 
\@mainmattertrue
\def\chaptername{Chapter}
\def\frontmatter{%
  \pagenumbering{roman}
  \def\thechapter{\@roman\c@chapter}
  \def\theHchapter{\roman{chapter}}
  \def\thesection{\@roman\c@section}
  \def\theHsection{\roman{section}}
  \def\@chapapp{}%
}
\def\mainmatter{%
  \cleardoublepage
  \def\thechapter{\@arabic\c@chapter}
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \pagenumbering{arabic}
  \setcounter{secnumdepth}{6}
  \def\@chapapp{\chaptername}%
  \def\theHchapter{\arabic{chapter}}
  \def\thesection{\@arabic\c@section}
  \def\theHsection{\arabic{section}}
}
\def\backmatter{%
  \cleardoublepage
  \setcounter{chapter}{0}
  \setcounter{section}{0}
  \setcounter{secnumdepth}{2}
  \def\@chapapp{\appendixname}%
  \def\thechapter{\@Alph\c@chapter}
  \def\theHchapter{\Alph{chapter}}
  \appendix
}
\newenvironment{bibitemlist}[1]{%
   \list{\@biblabel{\@arabic\c@enumiv}}%
       {\settowidth\labelwidth{\@biblabel{#1}}%
        \leftmargin\labelwidth
        \advance\leftmargin\labelsep
        \@openbib@code
        \usecounter{enumiv}%
        \let\p@enumiv\@empty
        \renewcommand\theenumiv{\@arabic\c@enumiv}%
	}%
  \sloppy
  \clubpenalty4000
  \@clubpenalty \clubpenalty
  \widowpenalty4000%
  \sfcode`\.\@m}%
  {\def\@noitemerr
    {\@latex@warning{Empty `bibitemlist' environment}}%
    \endlist}

\def\tableofcontents{\section*{\contentsname}\@starttoc{toc}}
\parskip0pt
\parindent1em
\def\Panel#1#2#3#4{\multicolumn{#3}{){\columncolor{#2}}#4}{#1}}
\newenvironment{reflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemsep}{0pt}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\itshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{sansreflist}{%
  \begin{raggedright}\begin{list}{}
  {%
   \setlength{\topsep}{0pt}%
   \setlength{\rightmargin}{0.25in}%
   \setlength{\itemindent}{0pt}%
   \setlength{\parskip}{0pt}%
   \setlength{\itemsep}{0pt}%
   \setlength{\parsep}{2pt}%
   \def\makelabel##1{\upshape ##1}}%
  }
  {\end{list}\end{raggedright}}
\newenvironment{specHead}[2]%
 {\vspace{20pt}\hrule\vspace{10pt}%
  \phantomsection\label{#1}\markright{#2}%

  \pdfbookmark[2]{#2}{#1}%
  \hspace{-0.75in}{\bfseries\fontsize{16pt}{18pt}\selectfont#2}%
  }{}
      \def\TheFullDate{2017-01-15 (revised: 15 January 2017)}
\def\TheID{\makeatother }
\def\TheDate{2017-01-15}
\title{Anti-Cancer Activities of Cu(?) Ion Solution in Progression and Development against Cancer and Tumor Cells}
\author{}\makeatletter 
\makeatletter
\newcommand*{\cleartoleftpage}{%
  \clearpage
    \if@twoside
    \ifodd\c@page
      \hbox{}\newpage
      \if@twocolumn
        \hbox{}\newpage
      \fi
    \fi
  \fi
}
\makeatother
\makeatletter
\thispagestyle{empty}
\markright{\@title}\markboth{\@title}{\@author}
\renewcommand\small{\@setfontsize\small{9pt}{11pt}\abovedisplayskip 8.5\p@ plus3\p@ minus4\p@
\belowdisplayskip \abovedisplayskip
\abovedisplayshortskip \z@ plus2\p@
\belowdisplayshortskip 4\p@ plus2\p@ minus2\p@
\def\@listi{\leftmargin\leftmargini
               \topsep 2\p@ plus1\p@ minus1\p@
               \parsep 2\p@ plus\p@ minus\p@
               \itemsep 1pt}
}
\makeatother
\fvset{frame=single,numberblanklines=false,xleftmargin=5mm,xrightmargin=5mm}
\fancyhf{} 
\setlength{\headheight}{14pt}
\fancyhead[LE]{\bfseries\leftmark} 
\fancyhead[RO]{\bfseries\rightmark} 
\fancyfoot[RO]{}
\fancyfoot[CO]{\thepage}
\fancyfoot[LO]{\TheID}
\fancyfoot[LE]{}
\fancyfoot[CE]{\thepage}
\fancyfoot[RE]{\TheID}
\hypersetup{citebordercolor=0.75 0.75 0.75,linkbordercolor=0.75 0.75 0.75,urlbordercolor=0.75 0.75 0.75,bookmarksnumbered=true}
\fancypagestyle{plain}{\fancyhead{}\renewcommand{\headrulewidth}{0pt}}

\date{}
\usepackage{authblk}

\providecommand{\keywords}[1]
{
\footnotesize
  \textbf{\textit{Index terms---}} #1
}

\usepackage{graphicx,xcolor}
\definecolor{GJBlue}{HTML}{273B81}
\definecolor{GJLightBlue}{HTML}{0A9DD9}
\definecolor{GJMediumGrey}{HTML}{6D6E70}
\definecolor{GJLightGrey}{HTML}{929497} 

\renewenvironment{abstract}{%
   \setlength{\parindent}{0pt}\raggedright
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
   \textcolor{GJBlue}{\large\bfseries\abstractname\space}
}{%   
   \vskip8pt
   \textcolor{GJMediumGrey}{\rule{\textwidth}{2pt}}
   \vskip16pt
}

\usepackage[absolute,overlay]{textpos}

\makeatother 
      \usepackage{lineno}
      \linenumbers
      
\begin{document}

             \author[1]{D. Sc Tsuneo  Ishida}

\renewcommand\Authands{ and }

\date{\small \em Received: 14 December 2016 Accepted: 1 January 2017 Published: 15 January 2017}

\maketitle


\begin{abstract}
        


Copper plays important role of cancer cell progression and development, malignant cell growth, and angiogenesis in invasive and metastatic growths. Specially, angiogenesis and autophagy have been worthy of new blood vessel formations and fusion proteins respectively for malignant and tumor cell growths. Schiff base copper(?) complexes have anti-proliferative activity against cancer cells. Cu2+ ions play an important role as pro-cancer factor in tumor tissues especially in tumor angiogenesis, invasion, and metastasis.Specially, Cu2+ ions as Cu-chelating complex can inhibit formation of new blood vessel of tumor cell against angiogenesis in cancer.Promotion and development of cancer tissues have been proceeding with homeostatic imbalances of copper, in which can be caused by the uptake of excessive amounts of copper and some genetic defects.Cancer cell killing via ROS that superoxide anion O2 ?, hydroxyl radical ?OH, hydrogen peroxide H2O2 mainly may be performed under cellular Cu2+ ions induced ROS generations in tumor cells. Finally, Cu2+-H2O2 induced DNA base-pairs inhibition can be regarded as being undergone to DNA damages due to Cu2+- complex formations within DNA base-pairs G?C, A=T by Cu2+ substitutions in hydrogen bonds of DNA base-pairs.

\end{abstract}


\keywords{copper(?) and copper(?) ions, cancer and tumor cells, angiogenesis, reactive oxygen species (ROS), DNA base-pairs}

\begin{textblock*}{18cm}(1cm,1cm) % {block width} (coords) 
\textcolor{GJBlue}{\LARGE Global Journals \LaTeX\ JournalKaleidoscope\texttrademark}
\end{textblock*}

\begin{textblock*}{18cm}(1.4cm,1.5cm) % {block width} (coords) 
\textcolor{GJBlue}{\footnotesize \\ Artificial Intelligence formulated this projection for compatibility purposes from the original article published at Global Journals. However, this technology is currently in beta. \emph{Therefore, kindly ignore odd layouts, missed formulae, text, tables, or figures.}}
\end{textblock*}


\let\tabcellsep& 	 	 		 
\section[{Introduction}]{Introduction}\par
opper is essential trace element that has the catalysis of a wide range of enzymatic activities, including those involved in the processes of energy production such as cytochrome oxidase, the cell response to oxidant injuries of Cu-Zn superoxide dismutase(SOD). In healthy human adults, the necessity ion is reduced to Cu + and then carried into cells by various transmembrane transporters. Copper and zinc are essential for optimal innate immune function and susceptibility to bacterial infection \hyperref[b0]{1} .In the blood, the major copper carrying proteins is ceruloplasmin \hyperref[b1]{2} and the rest of copper is transported by albumin and histidine \hyperref[b3]{3} .Formation of new blood vessels by a tumor enable tumor growth, invasion, and metastasis facilitates easily to occur. Then, organic chelators of copper can passively reduce cellular copper and serve copper has been shown to inhibit angiogenesis in a wide variety of cancer cell and xenograft system \hyperref[b24]{4} . Antiangiogenic strategies of blood vessel for performed \hyperref[b24]{4} , in which are the embryological formation of new blood vessels, the remodeling of an existing artery to increase its cross-section in response to increased blood flow, and the budding of new capillary branches from existing blood vessels \hyperref[b24]{4} .The progenitor cells migrate to sites of vascularization and differentiate into endothelial cells, forming the vascular plexus.\par
Especially, copper has been suggested as an important co-factor for angiogenesis \hyperref[b5]{5} . It is also a major copper ion that having been found in variety of tumor tissues and copper-mediated tumor proteasome inhibition \hyperref[b6]{6} .Several clinical trials using copper chelation as either an adjuvant or primary therapy have been conducted.Copper can influence the major stages of tumorigenesis-initiation, promotion, progression, significant role for autophagy of anticancer immunity and immunogenicity,autophagy of tumor antigen, and autophagy in cancer immunotherapy based on preclinical references \hyperref[b7]{7} .Further, copper dependent oxidative damage can be prevented by chelation with the antioxidants dipeptides which with imidazole ring chelate copper.As cancer cells exist probably under significant oxidative stress, the cytotoxic levels could be a successful anticancer approach, in which leads to ROS ( O 2 to H 2 O 2 ) and oxygen by generations of copper-zinc SOD enzymes \hyperref[b8]{8} .\par
On the other hand, cancer is one of the leading causes of mortality and represents a tremendous burden on patients and societies.Colorectal cancers are associated with one of the highest morbidity and mortality rates in both men and women.Cancer arises from a single cell, in which malignant tumors are described as monoclonal, meaning that each tumor arises from a single cell. Cancer cells are characterized by increased proliferation and reduced apoptosis.The development of a malignant tumor from a normal cell usually inhibitions forthe driving force in cancer progression may be various molecular such as Tumor microenvironment \hyperref[b11]{11} , K-ras mutations \hyperref[b12]{12} , and Haplo-insufficiency \hyperref[b13]{13} as a driving force are new findings highlight to investigate cancer invasion and metastasis.Recently, it is worth noting that copper chelation \hyperref[b14]{14} and Cu-polymer compounds \hyperref[b15]{15} kill the cancer cells with copper-binding protein formations  {\ref 16} .Thus, copper is a vital mineral essential for many biological processes, in which copper also plays an important role in promoting physiological and malignant angiogenesis.Copper deficiency as an anti-cancer strategy is that in an early(phase?) clinical trial have led to ongoing phase?evaluation of the copper chelatorTetrathiomolybdate(TM, as an anti-angiogenic agent) in patients with advanced cancers \hyperref[b17]{17} . The TM may be most beneficial for patient with minimal disease burden in the metastatic setting, in which ongoing phase studies as well as future trials will attempt to exploit this knowledge to define the role of TM in cancer treatment. The other, the vast majorityof all Cu in healthy humans is associated with enzyme prosthetic groups or bound to proteins.Excess or toxicity of Cu, which is associated with the pathogenesis of hepatic disorder, neurodegenerative changes and other disease condition, can occur when Cu homeostasis is disrupted \hyperref[b18]{18} .\par
In this review, it has becoming revealed on the standpoint of the results obtained from Cu 2+ ion killing mechanism against bacteria whether Cu 2+ ions and its compounds may be directly suppressed against the cancer and tumor cells. 
\section[{II.}]{II.} 
\section[{Bacteriolysis of s.aureus pgn and e.coli Outer Membrane Cell Walls}]{Bacteriolysis of s.aureus pgn and e.coli Outer Membrane Cell Walls}\par
Cu 2+ ions are important as antibacterial agents cells. Table \hyperref[tab_0]{1} shows the bacteriostasis as disinfection agent inhibiting the bacteria growth and multiplying organism of Cu 2+ ion, in which minimum inhibitory Cu 2+ ion concentration range of 0.10?50 mg/L against E.coli 19 .Table \hyperref[tab_1]{2} indicates the results as bactericide action, in which MIC=625 mg/L and minimum bactericide concentration, MBC=1250 mg/L were obtained for Cu 2+ ion concentration range of 9.8?5000 mg/L against S.aureus 20 . The killing curve of Cu 2+ ions is shown in Fig. 1 (measurement's error=±6\%), in which killing effects for the copper(?) ions appear sufficiently. Killing mechanisms of Cu 2+ ion solutions against bacteria are outlined below.?Bacteriolysis of S.aureus peptidoglycan(PGN) cell wall by Cu 2+ ions is ascribed to the inhibition of PGN elongation due to the damages of PGN biosynthesis; transglycosylase (TG), transpeptidase (TP) and the activations of PGN autolysins. The other,?bacteriolysis of E.coli outer membrane cell wall by Cu 2+ ions is attributed to the destruction of outer membrane structure and to the inhibition of PGN elongation due to the damage of PGN biosynthesis TP \hyperref[b20]{21} and the activations of PGN autolysins \hyperref[b21]{22} .    
\section[{Cancer Development and Progression}]{Cancer Development and Progression}\par
Cancer process is comprised of initiated cancer, development and progression of cancer, proliferation, invasion, and metastasis.Progression process of cancerous changes is considered for the cancer and tumor cells in the following: ? Abnormal cell generation ? ? Formation of malignant cell and growth ? ? ? Dedifferentiation and stage of propagation in single cell.\par
Copper becomes an essential cofactor for cancer cell proliferation, differentiation, invasion, and metastasis,and apoptosis and necrosis.\par
Carcinogenesis follows the activation of oncogenes and the deactivation of tumor suppression genes.Apoptosis is highly regulated process of cell death in the development and maintenance of a normal cell population in mature organism. Deregulation of apoptosis pathways is thus a key feature of promotion, malignant cell,cell invasion and metastasis against cancer and tumor cells. 
\section[{a) Cancer prevention and initiated process}]{a) Cancer prevention and initiated process}\par
Clioquinol(CQ)-CuCl 2 mixture \hyperref[b25]{23} indicates a formation of a stable CQ-Cu complex, and 1,10phenanthroine \hyperref[b26]{24} promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome activity.\par
Catechins, the dietary phytochemicals present in green tea and other beverages, are considered to bepotent inducers of apoptosis and cytotoxicity to cancer cells, in which the antioxidant properties make cancer induction lowering and impeding oxidative injury to DNA \hyperref[b27]{25} . The cellular DNA breakage was found to be significantly enhanced in the presence of copper ions. These Cu complexes play role of cancer prevention. 
\section[{b) Promotion}]{b) Promotion}\par
Initiation process: copper(?) ions inactivateCu 2+ + -SH ? -SCu(?) + H +\par
Oxygen in the cell varies reductive superoxide anion, that generates hydrogen peroxide. Volume XVII Issue VI Version IO 2 + e -? O 2 - 2O 2 -+ 2H + ? H 2 O 2 + O 2 O 2 - ? H 2 O 2 ? OH -+ ?OH + O 2 - O 2 + e -+ H + ? ?HO 2 ?HO 2 ? H + + O 2Year 2017 ( D D D D ) K Cu 2+ + O 2 - ? Cu + + O 2 Cu + + H 2 O 2 ?Cu 2+ + ?OH + OH - c) Progression\par
Progression of cancer or tumor cell is carcinogenesis, oncogenesis, epigenesis \hyperref[b28]{26} and the migration for intercellular ion channels \hyperref[b29]{27} are focused on the identification. Epigenetics in carcinogenesis, progression, and metastasis occurring from cancer stem cell have investigated that many epigenetic changes such as hypomethylation of oncogenes, hypermethylation of tumor suppressor genes, are known to be associated with many cancers. The other, the intracellular ion channels have emerged as oncogenic proteins, since they have an aberrant expression in cancers compared to normal tissues and contribute to several hallmarks of cancer. Carcinogenesis follows the activation of oncogenes and the deactivation of tumor suppression genes. Cu 2+ induced initial cancer cell ROS production and oxidative stress against tumor cell \hyperref[b30]{28} .\par
In free radicals (O 2 -, H + , OH -,?OH) and H 2 O 2 are formed as follows \hyperref[b31]{29} :?O 2 -+ 2H + + e -? H 2 O 2 H 2 O 2 + e -? HO -+ ?OH ?OH + e -+ H + ? H 2 O 2H + + ?O 2 -+?O 2 -? H 2 O 2 + O 2 H 2 O ? ?OH + ?H + e -? H 2 O 2\par
In the cell wall, reacting with polyunsaturated fatty acids(L=Organic ligand).:LH + OH? ? L? + HOH L? + O 2 ? LOO? LH + LOO? ? L? + LOOH Haber-Weiss reaction 30 ; H 2 O 2 + O 2 -? ?OH +OH -+O 2 Fenton reaction 31 ; Cu + ?H 2 O 2 ? ?OH ?OH -+ Cu 2+\par
Furthermore, new ROS productions occur by Fenton-like type. L=LigandLCu(?) + H 2 O 2 ? LCu(?)+ ?OOH + H ? LCu(?)?H 2 O 2 ? LCu(?)??OH + OH -\par
The other, relation of oxidative stress and autophagy has been investigated for copper ion in Cu 2 O, CuO crystals. The aqueous systems as following reaction \hyperref[b34]{32} :Cu 2 O + 2H + ? 2Cu + + H 2 O and CuO + 2H + ? Cu 2+ + H 2 O\par
Cu + ion is unstable and easily oxidized to Cu 2+ ion in aqueous system by Fenton reaction. Hence, in blood it is not proper as Cu + ion rapidly is oxidized to Cu 2+ ion. However, although "self-eating" by autophagy can potentially lead to cell death when cytoplasmic cellular organelles are consumed beyond a critical-forcell-survival point, it is unclear whether autophagy represent an active dying mode or the cell desperate, and often exhausted, attempt to survive. 
\section[{d) Invasion and metastasis}]{d) Invasion and metastasis}\par
Cancer cell invasion has collective and individual cell migrations, by which cancer cells invade other tissues either by moving collectively as epithelial sheets or detached cluster, or as single cells via mesenchymal or amoeboid cell types \hyperref[b35]{33} . During cancer progression, a variety of tumor cells show changes in their plasticity by morphological and phenotypical conversions, including the epithelial to mesenchymal transition (EMT). EMT has been increasingly recognized as crucial events in cancer progression and metastasis. Human epithelial cells predominantly migrate collectively, while most cells observed in vivo using intravital techniques and in vitro studies migrate as single cells \hyperref[b36]{34} .\par
The other, metastasis is a multi-step process encompassing, ? the local infiltration of tumor cells into the adjacent tissue, ? transendothelial migration of cancer cells into vessels known as intravasation, ? survival in the circulatory system, ? extravasation and ? subsequently, proliferation in competent organs leading to colonization \hyperref[b37]{35} . The rate-determining step process is that there is great interest in understanding the regulation of cellular adhesion metal-protein molecule. The epithelial to mesenchymal transition (EMT) is observed phenomenon that is a vital aspect of embryogenesis as well as cancer progression. During the EMT, cancer cells lose their adhesion and begin the process of metastasis ?. The process of cancer cell transition from EMT plays a dominant role in facilitating metastasis and progression in many types of cancer. Cuprous oxide nanoparticle (CONPs) induce mitochondria-mediated apoptosis, indicating that can inhibit the growth and metastasis of cancer cells \hyperref[b38]{36} . 
\section[{IV.}]{IV.}\par
Cu  {\ref 2+}  Peptide copper complex may be formed as 3N-Cu-O, Cu(Gly-L-Ala)H 2 O. Specially,Cu 2+ ions react with such as cross linked molecular penta glycine(Gly) 5 , copper-glycine complex may be formed. 
\section[{b) Autophagy in cancer cell}]{b) Autophagy in cancer cell}\par
Autophagy plays an important role in cancer and tumor cells. However, how autophagy contributes to cancer ontogenesis and progression has turned out to be more complex than expected. It must be clear whether Cu 2+ ions induced autophagy or necrotic cell death. Autophagy is to be function as tumor suppression of damaged organelles/proteins, and to confer stress tolerance that can maintain tumor cell, and to be a mechanism of cell death. MCF-7 cells influenced with tested Cu(?) complexes produced LC3 protein after 72 hours incubation indicating autophagy in MCF-7 cancer cells \hyperref[b39]{37} . Further, the specific nanomedicine induced phage fusion protein in cancer cell occur, that has shown significant improvements in the therapeutic activity of currently existing drug delivery system, such as liposomal doxorubicin. Thus, this fact is implicated that in the cancer and tumor cells, the killing modes are elucidated, it must be clear in this study that the inhibitions of progression and development, invasion, and metastasis of tumor cell occur by Cu 2+ induced autophagy fusion proteins in cancer and tumor cells \hyperref[b40]{38} . Furthermore, autophagic anticancer immunity pays attention in which autophagy affects the anti-cancer immune response. Accumulated studies have demonstrated that triggering autophagy is able to facilitate anticancer immunity due to an increase in immunogenicity, whereas other studies suggested that autophagy is likely to disarm anticancer immunity mediated by nature killer(NK) cell.Cu 2 O crystals promote endothelial cell death via Cu + induced autophagy, and elevate the level of reactive oxygen species such as superoxide and nitric oxide \hyperref[b38]{36} .Active role of autophagy as a cell death mechanism can be in principle validated by experiments documenting prolongation of survival upon autography downregulation \hyperref[b38]{36} . However, the endothelial cell death by Cu + ion induced autophagy is unclear whether the tumor death is due to fusion proteins in process of autophagy \hyperref[b40]{38} . 
\section[{c) Cu 2+ ions, copper complexes and copper-chelating suppress tumor development and angiogenesis in the cancer cell}]{c) Cu 2+ ions, copper complexes and copper-chelating suppress tumor development and angiogenesis in the cancer cell}\par
Tumors are to grow and thrive that they must develop a blood supply. Thus, it is said that every increment in tumor growth requires an increment in capillary growth, in which neovascularization or mechanism by that tumor cells elicit new blood vessel growth from the surrounding tissue. Angiogenesis is a complex process with many different growth factor and inhibited by a diverse range of proteins. The molecules secreted by tumors act on stromal cells in a paracrine fashion, so that can have different activities with the production and secretion of antiangiogenic proteins.\par
Copper is required for high levels of angiogenesis, in which copper requirement is due to many angiogenic factors. Angiogenesis relies on the coordination with many different activities in copper complex and copperchelating for suppressor tumor.\par
Copper as a neovascular agent is required for angiogenesis, in which micro-molar amounts of Cu(10 -6 M), thus appeared to control endothelial cell migration and angiogenesis. Copper was shown to stimulate blood vessel formation in the avascular cornea of rabbits, only recently have clinical trials established that Cu privation by diet or by Cu chelators diminishes a tumor's ability to mount an angiogenic response \hyperref[b41]{39} .Nanoparticles of copper(NanoCu) stimulate Tetrathiomolybdate(MoS 4 2-,TM) \hyperref[b43]{41} is a very promising antiangiogenic agent, and a potent metal chelator that binds Cu to proteins such as serum albumin, forming a complex that is only sparingly taken up by cells. The underlying concept for TM efficacy as an anticancer agent is that when the copper status is in the window, cellular copper needs are met and toxicity is avoided. Copper deficiency induced TM \hyperref[b44]{42} , depletion of copper \hyperref[b45]{43} and copper-lowering \hyperref[b46]{44} were significantly impaired tumor growth and angiogenesis, encouraging results in canine study of advanced and metastatic cancer. Further, the copper-chelating agents are efficient for Trientine Dihydrochloride (trientine), suppressor tumor development and angiogenesis \hyperref[b10]{10} .  {\ref 2+} -DNA: Cu  {\ref 2+} substitution to hydrogen bond in DNA base pairs Cu 2+ ion induced occurrence of generations of ROS and hydrogen peroxide H 2 O 2 in tumor cells damages DNA in tumor, in which formation of DNA angiogenesis at molecular level \hyperref[b42]{40} . NanoCu affect the development of blood vessel and muscles in a different manner than Cu salts, in which have pro-angiogenic properties at the systemic level, to a greater degree than CuSO 4 salt. The other, NanoCu also were confirmed that demonstrating significant effects on mRNA concentration and on mRNA gene expression of all proangiogenic and pro-proliferative genes measured. K damage resulting from a release of catalytic copper and binding of copper to DNA with generation of ?OH radicals, and by reaction of H 2 O 2 with the metal produces the strand breaks in DNA as well as DNA base modifications and deoxyribose fragmentation. It has been found that in aqueous solution coordination of Cu 2+ to the N7 and N1 sites of purine rings is pH dependent and coordination to N7 action tending to bind purine base A(adenine), G(guanine) and pyrimidine base C(cytosine), T(thymine) of nucleic acid bases for individual metals are indicated \hyperref[b47]{45} , depending on acid dissociation constant pK a . According to the theory, it is shown in Fig. \hyperref[fig_0]{2}, that is represented to substituting of Cu 2+ ions into hydrogen bonds in DNA base-pairing G?C and A=T pairs. Thus, it may be considered that DNA damages due to copper complexes formation within DNA base-pairs G?C, A=Toccur in cytoplasm of cancer cell. 
\section[{d) Copper-nucleotide interaction and Cu}]{d) Copper-nucleotide interaction and Cu} 
\section[{e) Copper complexes induced the killing, the regulation, the suppressor against cancer and tumor cells}]{e) Copper complexes induced the killing, the regulation, the suppressor against cancer and tumor cells}\par
Copper compounds, complexes, and chelation act beneficial for specific malignant tumors. The high against cancer cell of metastatic liver cancer, prostate cancer that supplementing with Cu, DS is highly toxic to cancer cell \hyperref[b48]{46,} {\ref 47} . Anticancer activity is exhibited by copper(?) complex possessing pyridinetype ligands(pyridine, bipyridine, phenanthroline etc.) or such where copper(?) ion is coordinated to phosphine ligands. 
\section[{Casiopeinas, copper coordinated complexes of Cu(N-N)(A-A)NO 3 , (A-A=N-O,O-O))}]{Casiopeinas, copper coordinated complexes of Cu(N-N)(A-A)NO 3 , (A-A=N-O,O-O))}\par
with perceptible antineoplastic effects on human malignant glioma had been investigated \hyperref[b52]{50,}\hyperref[b53]{51,}\hyperref[b54]{52} . The result is that the Casiopenia?-ia significantly inhibited cell proliferation and cell death, inducing autophagy and apoptosis of glioma cells, which correlated with the formation of autophagic vacuoles, over expression of Bax and Bid proteins. New uses for old copper binding drugs 53 is approached to discover new application for a specific cancer cell death inducer, including pro-angiogenic process.    
\section[{Conclusions}]{Conclusions}\par
Cu 2+ ions have numerous roles in cancer prevention, initiation of carcinogenesis, progression of uncontrolled cell growth, malignant tumor cell growth, invasive growth as malignancy, and metastasis of downregulation of cell adhesion and cell-cell attachment, by Cu(?)/Cu(?) redox reaction cycles and Cu 2+ ion induced ROS productions.Angiogenesis and autophagy play an important role in cancer and tumor cells. Schiff base copper(?) complexes have anti-proliferative activity against cancer cells. Cu 2+ ions play an important role as pro-cancer factor in tumor tissues, especially in tumor angiogenesis,invasion, and metastasis. Cu 2+ ions blood vessel of tumor cell against angiogenesis in cancer.Promotion and development of cancer tissues have been proceeding with homeostatic imbalances of copper, in which can be caused by the uptake of excessive amounts of copper and some genetic \begin{figure}[htbp]
\noindent\textbf{2}\includegraphics[]{image-2.png}
\caption{\label{fig_0}K 2 -}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{15}\includegraphics[]{image-3.png}
\caption{\label{fig_1}1 proteasome 5 ,K}\end{figure}
      \begin{figure}[htbp]
\noindent\textbf{1} \par 
\begin{longtable}{P{0.18214285714285713\textwidth}P{0.13443877551020408\textwidth}P{0.013010204081632653\textwidth}P{0.021683673469387755\textwidth}P{0.1691326530612245\textwidth}P{0.021683673469387755\textwidth}P{0.15612244897959185\textwidth}P{0.021683673469387755\textwidth}P{0.021683673469387755\textwidth}P{0.021683673469387755\textwidth}P{0.021683673469387755\textwidth}P{0.06505102040816327\textwidth}}
Cu 2+ solution\tabcellsep \tabcellsep \tabcellsep \tabcellsep \multicolumn{5}{l}{Cu 2+ solution concentration(mg/L)}\tabcellsep \tabcellsep \tabcellsep MIC\\
agent? original conc\tabcellsep 50\tabcellsep 25\tabcellsep 12.5\tabcellsep 6.25\tabcellsep 3.13\tabcellsep 1.56\tabcellsep 0.78\tabcellsep 0.39\tabcellsep 0.20\tabcellsep 0.10\tabcellsep 50 mg/L\\
500 mg/L\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep ?\tabcellsep above\\
\tabcellsep \multicolumn{4}{l}{(?)?Visible bacterial growth}\tabcellsep \tabcellsep \multicolumn{4}{l}{(-)?No visible bacterial growth}\tabcellsep \tabcellsep \end{longtable} \par
 
\caption{\label{tab_0}Table 1 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{2} \par 
\begin{longtable}{P{0.2406392694063927\textwidth}P{0.09315068493150684\textwidth}P{0.09315068493150684\textwidth}P{0.09315068493150684\textwidth}P{0.19406392694063926\textwidth}P{0.05045662100456621\textwidth}P{0.019406392694063926\textwidth}P{0.01552511415525114\textwidth}P{0.01552511415525114\textwidth}P{0.01552511415525114\textwidth}P{0.019406392694063926\textwidth}}
Antibacterial agent\tabcellsep \tabcellsep \tabcellsep \tabcellsep \multicolumn{4}{l}{Cu 2+ concentration(mg/L)}\tabcellsep \tabcellsep \tabcellsep \\
Cu(NO 3 ) 2 3H 2 Osolution\tabcellsep 5000\tabcellsep 2500\tabcellsep 1250\tabcellsep 625\tabcellsep 313\tabcellsep 156\tabcellsep 78\tabcellsep 39\tabcellsep 20\tabcellsep 9.8\\
MIC\tabcellsep \textunderscore \tabcellsep \textunderscore \tabcellsep \textunderscore \tabcellsep \textunderscore \tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\\
MBC\tabcellsep -\tabcellsep -\tabcellsep -\tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\tabcellsep +\\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep 3.1\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep ×\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
CFU(cfu/mL)\tabcellsep ?10\tabcellsep ?10\tabcellsep ?10\tabcellsep \tabcellsep ×\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep 10 2\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \\
\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep 10 8\tabcellsep \tabcellsep \tabcellsep \tabcellsep \tabcellsep \end{longtable} \par
 
\caption{\label{tab_1}Table 2 :}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{} \par 
\begin{longtable}{P{0.85\textwidth}}
Cu 2+ ions are in turn reduced to Cu (?) ions by which is partial action sites of glycan saccharide chains.\\
superoxide anion O 2 -. The copper (?) ions can reduce L is coordinated molecular.\\
hydrogen peroxide H 2 O 2 to hydroxyl radical ?OH. Cu 2+ + LH ? CuL + + H +\\
CuL + + LH ? CuL 2 + H +\\
Cu 2+ ? 2LH ? CuL 2 ? H +\\
considered that the uncontrolled cell growth for a\\
Year 2017\\
Volume XVII Issue VI Version I\\
D D D D ) K\\
(\\
Reactive oxygen species (ROS) O 2 -and H 2 O 2\\
generated in cell wall permeate into cell membrane and\\
cytoplasm, in which in cell membrane high reactive\\
?OH and OH -are formed by Haber-Weiss and Fenton\\
reactions.\\
a) Cu 2+ ions binding with amino, peptide, protein of\\
cancer cell tissues\\
Cu 2+ ions inhibit polymerization of glycan\\
chains, to be thought to be forming copper complex in\end{longtable} \par
 
\caption{\label{tab_2}}\end{figure}
 \begin{figure}[htbp]
\noindent\textbf{3} \par 
\begin{longtable}{P{0.49020332717190385\textwidth}P{0.3597966728280961\textwidth}}
Furthermore, the copper chelation kills the cancer and\tabcellsep tumor growth. Killing of cancer cell is induced via ROS\\
tumor cells, in which an alternative Cu-chelators 10 and\tabcellsep mainly consisting of singlet oxygen, O 2 -,?OH,and H 2 O 2 .\\
chelator 54 could inhibit and suppress neovascularization,\tabcellsep \\
increase of apoptosis in tumor growth, and\tabcellsep ions migration into initiation, progression, proliferation,\\
angiogenesis. Copper chelating complex can serve as\tabcellsep invasion, and metastasis against cancer and tumor\\
anti-angiogenic agent and ROS generators to inhibit\tabcellsep cells.\end{longtable} \par
 
\caption{\label{tab_3}Table 3 :}\end{figure}
 			\footnote{© 2017 Global Journals Inc. (US)} 		 		\backmatter  			  				\begin{bibitemlist}{1}
\bibitem[Raju et al.]{b1}\label{b1} 	 		\textit{},  		 			K S Raju 		,  		 			G Alessandri 		,  		 			M Ziche 		,  		 			P M Gullino 		.  		 	 
\bibitem[Ramachandran et al. ()]{b20}\label{b20} 	 		\textit{},  		 			V Ramachandran 		,  		 			B Chandrakala 		,  		 			V P Kumar 		,  		 			V Usha 		,  		 			S M Solapure 		,  		 			S M Sousa 		.  	 	 		\textit{Antimicrob Agents Chemother}  		2006. 50  (4)  p. .  	 	 (Screen for inhibitors of the coupled transglycosylasetranspeptidase of peptidoglycan biosynthesis in E.coli) 
\bibitem[ Cancer Research J ()]{b49}\label{b49} 	 		\textit{},  	 	 		\textit{Cancer Research J}  		2014. 2  (5)  p. .  	 	 (gluconate in cancer chemotherapy; a review of the literature) 
\bibitem[Baile (2015)]{b50}\label{b50} 	 		\textit{},  		 			M B Baile 		.  	 	 		\textit{ANTICANCER COPPER COMPLEX, International J. Pharma.Research \& Review}  		August. 2015. 4  (8)  p. .  	 
\bibitem[Ishida ()]{b19}\label{b19} 	 		‘) bacterial cell walls/cell membrane and DNA basepairing damages’.  		 			Tsuneo Ishida 		.  	 	 		\textit{The consideration of biocidal Gram-negative bacteria cell walls on the results of the susceptibility tests},  				2016. 2016. 55 p. .  		 			Nihon University 		 	 	 (Research Reports. in Japanese) 
\bibitem[Pena et al. ()]{b3}\label{b3} 	 		‘A Delicate Balance: Homeostatic Control of Copper Uptake and Distribution?’.  		 			Mmo Pena 		,  		 			J Lee 		,  		 			D J Thiele 		.  	 	 		\textit{J.Nutr}  		1999. 129 p. .  	 
\bibitem[Harris ()]{b41}\label{b41} 	 		‘A requirement for copper in angiogenesis’.  		 			Edward D Harris 		.  	 	 		\textit{Nutrition Reviews}  		2004. 62 p. .  	 
\bibitem[Hajrezaie ()]{b54}\label{b54} 	 		‘A Schiff base-derived copper(?) complex is a potent inducer of apoptosis in colon cancer cells by activating the intrinsic pathway’.  		 			Maryam Hajrezaie 		.  	 	 		\textit{The Scientific World J}  		2014. 2016. 45 p. .  	 	 (Eur Biophys J) 
\bibitem[Theophanides ()]{b8}\label{b8} 	 		‘Anastassopoulou: Copper and carcinogenesis’.  		 			T Theophanides 		,  		 			J 		.  	 	 		\textit{Oncology Hematology}  		2002. 42 p. .  	 
\bibitem[as Cu-chelating complex can inhibit formation of new]{b23}\label{b23} 	 		\textit{as Cu-chelating complex can inhibit formation of new},  		 	 
\bibitem[Li ()]{b7}\label{b7} 	 		‘Autophagic mechanism in anticancer immunity: its pros and cons for cancer therapy’.  		 			Ying-Ying Li 		.  	 	 		\textit{International Journal of Molecular Sciences}  		2017. 18 p. 1297.  	 
\bibitem[Wang and Yi ()]{b30}\label{b30} 	 		‘Cancer cell killing via ROS’.  		 			Jie Wang 		,  		 			Jing Yi 		.  	 	 		\textit{Cancer Biology \& Therapy}  		2008. 7  (12)  p. .  	 
\bibitem[Cancer cell killing via ROS that superoxide anion induced ROS generations in tumor cells. Finally, Cu 2+ -16. Stephanie Blockhuys and Pernilla Wittungrelationship key to cancer progression Tsuneo Ishida?Bacteriolyses of Cu 2+ solution on defects (2009)]{b22}\label{b22} 	 		‘Cancer cell killing via ROS that superoxide anion induced ROS generations in tumor cells. Finally, Cu 2+ -16. Stephanie Blockhuys and Pernilla Wittungrelationship key to cancer progression’.  	 	 		\textit{Tsuneo Ishida?Bacteriolyses of Cu 2+ solution on defects},  				2009 Jan. 36 p. .  	 
\bibitem[Farhan ()]{b27}\label{b27} 	 		‘Cancer therapy by catechins involves redox cycling of copper ions and generation of reactive oxygen species’.  		 			Mohd Farhan 		.  	 	 		\textit{Toxins}  		2016. 8 p. .  	 
\bibitem[Ceruloplasmin, copper ions, and angiogenesis J.Nat.Cancer. Inst ()]{b2}\label{b2} 	 		‘Ceruloplasmin, copper ions, and angiogenesis’.  	 	 		\textit{J.Nat.Cancer. Inst}  		1982. 69 p. .  	 
\bibitem[Daniel ()]{b25}\label{b25} 	 		‘Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells’.  		 			Kenyon G Daniel 		.  	 	 		\textit{Breast Cancer Research}  		2005. 7 p. .  	 
\bibitem[Karrera and Djoko ()]{b0}\label{b0} 	 		‘Copper and zinc toxicity and its role in innate immune defense against bacterial pathogens’.  		 			V Karrera 		,  		 			Djoko 		.  	 	 		\textit{The American Society for Biochemistry and Molecular Biology}  		2015. 8 p. .  	 
\bibitem[Trejo-Solis ()]{b52}\label{b52} 	 		‘Copper compound induces autophagy and apoptosis of glioma cells by reactive oxygen species and jnk activation’.  		 			Cristina Trejo-Solis 		.  	 	 		\textit{BMC Cancer}  		2012. 12 p. 156.  	 
\bibitem[V L Goodman et al. ()]{b17}\label{b17} 	 		‘Copper deficiency as an anti-cancer strategy’.  		 			G J V L Goodman 		,  		 			S D Brewer 		,  		 			Merajver 		.  	 	 		\textit{Endocrine-Related Cancer}  		2004. 11 p. .  	 
\bibitem[Pan ()]{b44}\label{b44} 	 		‘Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis’.  		 			Quintin Pan 		.  	 	 		\textit{Cancer Research}  		2002. 62 p. .  	 
\bibitem[Park et al.]{b55}\label{b55} 	 		\textit{Copper ion from Cu 2 O crystal 47},  		 			Haonyyong Park 		,  		 			; G Udeme 		,  		 			S I Minakiri 		.  		Disulfiram and copper.  	 
\bibitem[Copper-lowering therapy with tetrathiomolybdate for cancer and diseases of fibrosis and inflammation J. Trace Elements in Experimental Medicine ()]{b46}\label{b46} 	 		‘Copper-lowering therapy with tetrathiomolybdate for cancer and diseases of fibrosis and inflammation’.  	 	 		\textit{J. Trace Elements in Experimental Medicine}  		2003. 16 p. .  	 
\bibitem[Wang ()]{b38}\label{b38} 	 		‘Cuprous oxide nanoparticle inhibit the growth and metastasis of melanoma by targeting mitochondria’.  		 			Y Wang 		.  	 	 		\textit{Cell Death and Disease}  		2013. 4.  	 
\bibitem[Montagner ()]{b51}\label{b51} 	 		‘DNA damage and induction of apoptosis in pancreatic cancer cells by a new dinuclearbis (triazacyclonane) copper complex’.  		 			D Montagner 		.  	 	 		\textit{J.Inorganic Biochemistry}  		2015. 145 p. .  	 
\bibitem[Vera-Ramirez ()]{b31}\label{b31} 	 		‘Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies’.  		 			Laura Vera-Ramirez 		.  	 	 		\textit{Oncology Hematology}  		2011. 80 p. .  	 
\bibitem[Glesne: Copper and angiogenesis:Unravelling a]{b4}\label{b4} 	 		\textit{Glesne: Copper and angiogenesis:Unravelling a},  		 	 
\bibitem[Alice and Bergar ()]{b13}\label{b13} 	 		‘Haplo-insufficiency: a driving force in cancer’.  		 			H Alice 		,  		 			P Bergar 		,  		 			P 		,  		 			Pandolfi 		.  	 	 		\textit{J.Pathol}  		2010. 223 p. .  	 
\bibitem[Huacheng He et al: Cancer cell selective-killing polymer/copper combination Biomater Sci (2016)]{b15}\label{b15} 	 		‘Huacheng He et al: Cancer cell selective-killing polymer/copper combination’.  	 	 		\textit{Biomater Sci},  				2016 Jan. 4 p. .  	 
\bibitem[Humann and Lenz]{b21}\label{b21} 	 		 			Jessica Humann 		,  		 			Laurel L Lenz 		.  		\textit{Bacterial peptidoglycan degrading enzymes and their impact activities of Cu 2+ solutions in Gram-positive and},  				 	 
\bibitem[Brem ()]{b45}\label{b45} 	 		‘Inhibition of angiogenesis and tumor growth in the brain’.  		 			Steven S Brem 		.  	 	 		\textit{American J. Patbology}  		1990. 137 p. 1121.  	 
\bibitem[Franziska Van Zijl et al. ()]{b35}\label{b35} 	 		‘Initial steps of metastasis : Cell invasion and endothelial transmigration’.  		 			Georg Franziska Van Zijl 		,  		 			Wolfgang Krupitza 		,  		 			Mikulits 		.  	 	 		\textit{Mutation Research}  		2011. 728 p. .  	 
\bibitem[Margetis ()]{b12}\label{b12} 	 		\textit{K-ras Mutations as the Earliest Driving Force in a Subject of Colorectal Carcinomas},  		 			N Margetis 		.  		2017. p. .  	 
\bibitem[Konarikova ()]{b39}\label{b39} 	 		 			K Konarikova 		.  	 	 		\textit{Autophagy in MCF-7 cancer cells induced by Cu(?) complexes},  				2016. 8 p. .  	 
\bibitem[Krzyszt of BARBUSINSKI; Fenton reactioncontroversy concerning the chemistry ECOLOGICAL CHEMISTRY AND ENGINEERINGS]{b33}\label{b33} 	 		‘Krzyszt of BARBUSINSKI; Fenton reactioncontroversy concerning the chemistry’.  	 	 		\textit{ECOLOGICAL CHEMISTRY AND ENGINEERINGS}  		 	 
\bibitem[Peruzzo et al.]{b29}\label{b29} 	 		\textit{Leanza: Impact of intracellular ion channels on cancer development},  		 			R Peruzzo 		,  		 			L Biasutto 		,  		 			I Szabo 		,  		 			L 		.  		 	 
\bibitem[Lisa and Gaetke]{b18}\label{b18} 	 		 			M Lisa 		,  		 			Gaetke 		.  		\textit{Copper: Toxicological relevance},  				p. .  	 
\bibitem[Maamoun Fatfat etal : Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species BMC Cancer ()]{b14}\label{b14} 	 		‘Maamoun Fatfat etal : Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species’.  	 	 		\textit{BMC Cancer}  		2012. 14 p. .  	 
\bibitem[Massague and Obenauf (2016)]{b37}\label{b37} 	 		 			Joan Massague 		,  		 			Anna C Obenauf 		.  	 	 		\textit{Metastatic Colonization},  				2016 Jan 21. 529 p. .  	 
\bibitem[Brewer ()]{b43}\label{b43} 	 		‘Merajver: Cancer therapy with tetrathiomolybdate: Antiangiogenesis by lowering body copper’.  		 			George J Brewer 		,  		 			Solfiad 		.  	 	 		\textit{Integrative Cancer Therapies}  		2002. 1  (4)  p. .  	 
\bibitem[Zubair ()]{b9}\label{b9} 	 		‘Mobilization of intracellular copper by gossypol and apogossypolone leads to reactive oxygen species-mediated cell death: putative anticancer mechanism’.  		 			Haseeb Zubair 		.  	 	 		\textit{Int. J. Molecular Sciences}  		2016. 17 p. .  	 
\bibitem[Xiao ()]{b6}\label{b6} 	 		‘Molecular study on copper-mediated tumor proteasome inhibition and cell death’.  		 			Yan Xiao 		.  	 	 		\textit{Int J Oncol}  		2010July. 37  (1)  p. .  	 
\bibitem[Mroczek-Sosnowska ()]{b42}\label{b42} 	 		‘Nanoparticles of copper stimulate angiogenesis at systemic and molecular level’.  		 			Natalia Mroczek-Sosnowska 		.  	 	 		\textit{Int. J. Mol. Sci}  		2015. 16 p. .  	 
\bibitem[Sibaji Sarkar et al: Cancer development, progression, and therapy: An epigenetic overview Int.J.Mol.Sci ()]{b28}\label{b28} 	 		‘Sibaji Sarkar et al: Cancer development, progression, and therapy: An epigenetic overview’.  	 	 		\textit{Int.J.Mol.Sci}  		2013. 14 p. .  	 
\bibitem[
			AP
		 ()]{b53}\label{b53} 	 		‘Singh et al: Synthesis, structure and anticancer activities of copper(?) complexes’.  		 			AP 		.  	 	 		\textit{Indian J. Chemistry}  		2011. 50 p. .  	 
\bibitem[Stafshede: Roles of copper-binding proteins in breast cancer Int J Molecular Sciences ()]{b16}\label{b16} 	 		‘Stafshede: Roles of copper-binding proteins in breast cancer’.  	 	 		\textit{Int J Molecular Sciences}  		2017. 18 p. .  	 
\bibitem[Yoshi ()]{b10}\label{b10} 	 		‘The copper-chelating agent, trientine, suppresses tumor development and angiogenesis in the murine hepatocellular carcinoma cells’.  		 			Junichi Yoshi 		.  	 	 		\textit{Int. J. Cancer}  		2001. 94 p. .  	 
\bibitem[Tawari ()]{b48}\label{b48} 	 		‘The cytotoxic mechanisms of disulfiram and copper(?) in cancer cells’.  		 			Patricia Erebi Tawari 		.  	 	 		\textit{Toxicol. Research}  		2015. 4 p. .  	 
\bibitem[Lames and Kehrer ()]{b32}\label{b32} 	 		‘The Haber-Weiss reaction and mechanisms of toxicity’.  		 			P Lames 		,  		 			Kehrer 		.  	 	 		\textit{Toxicology}  		2000. 149 p. .  	 
\bibitem[Maskos (Polonica198)]{b47}\label{b47} 	 		‘The interaction of metal ions with nucleic acids. NMR study of the copper(?) interaction with inosine derivatives’.  		 			K Maskos 		.  	 	 		\textit{Acta Biochim}  		Polonica198. 28 p. .  	 
\bibitem[Yang ()]{b40}\label{b40} 	 		‘The role of autophagy induced by tumor microenvironment in different cells and stages of cancer’.  		 			Xue Yang 		.  	 	 		\textit{Cell Bioscience}  		2015. 5 p. .  	 
\bibitem[Finney and Vogt ()]{b24}\label{b24} 	 		‘Tohru Fukai, and David and mechanisms’.  		 			Lydia Finney 		,  		 			Stefan Vogt 		.  	 	 		\textit{J Innate Immun}  		2014. 2009. 88  (11)  p. .  	 	 (Arch Toxicol) 
\bibitem[Xie et al. ()]{b11}\label{b11} 	 		‘Tumor microenvironment: driving forces and potential therapeutic target for breast cancer metastasis’.  		 			Hong-Yan Xie 		,  		 			Zhi-Min Shao 		,  		 			Da-Qiang Li 		.  	 	 		\textit{Chinese J. Cancer}  		2017. 36 p. .  	 
\bibitem[Wang et al. ()]{b5}\label{b5} 	 		‘Turnig tumor-promoting copper into an anti-cancer weapon via high-throughput chemistry’.  		 			F Wang 		,  		 			P Jiao 		,  		 			M Qi 		,  		 			M Frezza 		,  		 			B Yan 		.  	 	 		\textit{Curr Med Chem}  		2010. 17  (25)  p. .  	 
\bibitem[Clark and Matic ()]{b36}\label{b36} 	 		‘Vignjevic: Modes of cancer cell invasion and the role of the microenvironment’.  		 			Andrew G Clark 		,  		 			D Matic 		.  	 	 		\textit{Current Opinion in Cell Biology}  		2015. 36 p. .  	 
\bibitem[Youngsikseo and Cho ()]{b34}\label{b34} 	 		‘Young-Duk Huh, and induces AMPK-mediated autography via superoxide in endothelial cells’.  		 			Young-Sik Youngsikseo 		,  		 			Cho 		.  	 	 		\textit{Mol.Cells}  		2016. 39  (3)  p. .  	 
\bibitem[Zhen Zhang et al: 1,10-phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome J. BiolInorgChem ()]{b26}\label{b26} 	 		‘Zhen Zhang et al: 1,10-phenanthroline promotes copper complexes into tumor cells and induces apoptosis by inhibiting the proteasome’.  	 	 		\textit{J. BiolInorgChem}  		2012. 17  (8)  p. .  	 
\end{bibitemlist}
 			 		 	 
\end{document}
